ATROPINE Drug Patent Profile
✉ Email this page to a colleague
When do Atropine patents expire, and what generic alternatives are available?
Atropine is a drug marketed by Abbvie, Rafa Labs Ltd, Us Army, Amneal, Apotex, Bausch And Lomb Inc, Mankind Pharma, Rising, Somerset, Somerset Theraps Llc, Accord Hlthcare, Am Regent, Hospira, Intl Medication Sys, Medefil Inc, Fresenius Kabi Usa, and Hikma. and is included in twenty-four NDAs.
The generic ingredient in ATROPINE is atropine sulfate. There are twenty-three drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the atropine sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Atropine
A generic version of ATROPINE was approved as atropine sulfate by HOSPIRA on July 9th, 2001.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ATROPINE?
- What are the global sales for ATROPINE?
- What is Average Wholesale Price for ATROPINE?
Summary for ATROPINE
| US Patents: | 0 |
| Applicants: | 17 |
| NDAs: | 24 |
| Raw Ingredient (Bulk) Api Vendors: | 59 |
| Clinical Trials: | 416 |
| Patent Applications: | 3,664 |
| Drug Prices: | Drug price information for ATROPINE |
| What excipients (inactive ingredients) are in ATROPINE? | ATROPINE excipients list |
| DailyMed Link: | ATROPINE at DailyMed |
Recent Clinical Trials for ATROPINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| New England College of Optometry | Phase 1 |
| University of Missouri, St. Louis | Phase 1 |
| Case Western Reserve University | Phase 1 |
Medical Subject Heading (MeSH) Categories for ATROPINE
Anatomical Therapeutic Chemical (ATC) Classes for ATROPINE
US Patents and Regulatory Information for ATROPINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma | ATROPINE SULFATE | atropine sulfate | SOLUTION;INTRAVENOUS, INTRAMUSCULAR, SUBCUTANEOUS, INTRAOSSEOUS, ENDOTRACHEAL | 213561-001 | Dec 1, 2021 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Somerset Theraps Llc | ATROPINE SULFATE | atropine sulfate | SOLUTION;INTRAVENOUS | 215969-001 | Jul 3, 2024 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Somerset Theraps Llc | ATROPINE SULFATE | atropine sulfate | SOLUTION;INTRAVENOUS | 215969-002 | Jul 3, 2024 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Abbvie | ATROPINE | atropine | SOLUTION;INTRAMUSCULAR | 071295-001 | Jan 30, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
